|
EP400 is required for Max and MCPyV mediated gene activation |
88.68 |
|
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module |
88.58 |
|
4sU-seq of HFF exposed to salt and heat stress |
57.89 |
|
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] |
36.5 |
|
Genome wide expression change by RNF168 knocking down in NEC cells |
36.37 |
|
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] |
36.29 |
|
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice |
36.29 |
|
RNA sequencing of GlyH-101-treated MCF-7 cell line |
36.13 |
|
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors |
34.12 |
|
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation |
28.36 |
|
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] |
28.15 |
|
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] |
27.51 |
|
Genome wide miR-191 target profile determined by RIP and gene expression profiling |
27.51 |
|
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation |
27.06 |
|
RIG-I and MDA5 fRIP during KSHV lytic reactivation |
26.32 |
|
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus |
25.87 |
|
Differential expression of genes in AD169-infected MRC5. |
25.37 |
|
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions |
25.13 |
|
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation |
24.39 |
|
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] |
23.3 |
|
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection |
23.08 |
|
Endothelial gene expression analysis |
21.4 |
|
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. |
21.4 |
|
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation |
21.3 |
|
RNA-seq in SUNE-1 cells after downregulation of DANCR expression |
20.61 |
|
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes |
20.45 |
|
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] |
20.45 |
|
FOXD3 is a novel tumor suppressor in lung cancer |
20.16 |
|
Gene expression changes after LOC550643 silencing |
19.79 |
|
Gene expression profile of LMSU gastric cancer cell p53 KO and KD |
19.2 |
|
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis |
18.99 |
|
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing |
18.62 |
|
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). |
18.44 |
|
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) |
18.35 |
|
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells |
18.17 |
|
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells |
18.17 |
|
Expression analysis of Mebendazole treated THP-1 cells in three paired samples |
18.02 |
|
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq |
17.75 |
|
Gene expression profiling of leukemia cells following asparagine depletion |
17.45 |
|
RNA-seq in transgenic cells |
17.02 |
|
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 |
16.79 |
|
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] |
16.79 |
|
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML |
16.68 |
|
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines |
16.68 |
|
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation |
16.25 |
|
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer |
16.18 |
|
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders |
16.12 |
|
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment |
16.0 |
|
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing |
15.79 |
|
The role of FAM46C in myeloma cells |
15.62 |
|
The role of FAM46C in myeloma cells [sequencing] |
15.62 |
|
MeRIP-seq for heat shock in B-cell lymphoma cells |
15.3 |
|
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma |
15.15 |
|
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) |
15.15 |
|
Modeling the MYC-driven normal-to-tumour switch in breast cancer. |
14.96 |
|
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells |
14.94 |
|
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing |
14.46 |
|
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer |
14.33 |
|
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction |
14.27 |
|
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) |
14.27 |
|
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements |
14.25 |
|
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] |
14.24 |
|
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies |
14.24 |
|
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML |
14.17 |
|
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor |
14.12 |
|
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] |
14.12 |
|
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) |
14.07 |
|
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation |
14.07 |
|
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells |
13.9 |
|
3’ Uridylation Expands miRNA Target Repertoire |
13.73 |
|
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock |
13.53 |
|
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] |
13.53 |
|
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons |
13.36 |
|
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers |
13.29 |
|
RNA-seq of resting and activated CD4+ T cells +-JQ1 |
13.23 |
|
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes |
13.22 |
|
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 |
13.18 |
|
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) |
13.13 |
|
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. |
13.08 |
|
MicroRNA targetome analysis during HCMV infection |
13.0 |
|
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites |
12.91 |
|
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis |
12.79 |
|
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation |
12.79 |
|
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro |
12.74 |
|
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells |
12.53 |
|
Exogenous rescue of KLHL9 in SF210 cell line |
12.5 |
|
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes |
12.38 |
|
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] |
12.33 |
|
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution |
12.33 |
|
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator |
12.24 |
|
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] |
12.24 |
|
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 |
12.2 |
|
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II |
12.19 |
|
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway |
12.12 |
|
Effect of FGF13 depletion on the H460 cell line |
12.1 |
|
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes |
11.98 |
|
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism |
11.96 |
|
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury |
11.86 |
|
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity |
11.82 |
|
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein |
11.63 |
|
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase |
11.54 |
|
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 |
11.52 |
|
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] |
11.52 |
|
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling |
11.52 |
|
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity |
11.49 |
|
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease |
11.37 |
|
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells |
11.27 |
|
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells |
11.27 |
|
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID |
11.26 |
|
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA |
11.23 |
|
A role for ZNF598 in post-transcriptional gene regulation |
11.22 |
|
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells |
11.15 |
|
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells |
11.14 |
|
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects |
11.06 |
|
Tumor hypoxia causes DNA hypermethylation by reducing TET activity |
11.01 |
|
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) |
11.01 |
|
Effect of disulfiram treatment on pediatric high grade glioma |
10.96 |
|
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program |
10.94 |
|
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia |
10.83 |
|
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] |
10.83 |
|
LncRNA-GAS5 negative regulation of YAP-target genes expression |
10.81 |
|
Transcriptome analysis upon C6orf203 silencing |
10.78 |
|
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation |
10.77 |
|
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) |
10.76 |
|
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection |
10.76 |
|
RNA sequencing of BT142 and TS603 cell lines |
10.76 |
|
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas |
10.76 |
|
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II |
10.74 |
|
Identification of transcription start sites for human A549 cell line using ReCappable-seq |
10.68 |
|
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells |
10.59 |
|
RNA sequencing of primary human platelets and in vitro cell lines |
10.59 |
|
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods |
10.55 |
|
CD73 knockdown effect in pancreatic cancer cell lines |
10.54 |
|
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG |
10.49 |
|
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network |
10.47 |
|
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] |
10.43 |
|
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens |
10.43 |
|
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells |
10.36 |
|
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma |
10.29 |
|
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) |
10.27 |
|
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction |
10.17 |
|
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer |
10.09 |
|
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] |
10.09 |
|
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells |
10.08 |
|
NRDE2 negatively regulates nuclear exosome functions |
10.08 |
|
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] |
10.07 |
|
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer |
10.07 |
|
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) |
9.96 |
|
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 |
9.94 |
|
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) |
9.94 |
|
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth |
9.93 |
|
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest |
9.9 |
|
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) |
9.89 |
|
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling |
9.89 |
|
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality |
9.8 |
|
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells |
9.76 |
|
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection |
9.74 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes |
9.73 |
|
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation |
9.68 |
|
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation |
9.68 |
|
Identification of Sin3B regulated genes during quiescence |
9.64 |
|
MYCi361 regulates MYC target genes |
9.62 |
|
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression |
9.6 |
|
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation |
9.57 |
|
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells |
9.53 |
|
Wnt addiction of genetically defined cancers reversed by PORCN inhibition |
9.53 |
|
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells |
9.49 |
|
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] |
9.49 |
|
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 |
9.48 |
|
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 |
9.48 |
|
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes |
9.46 |
|
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation |
9.46 |
|
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 |
9.44 |
|
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA |
9.43 |
|
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] |
9.42 |
|
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] |
9.4 |
|
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer |
9.4 |
|
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide |
9.39 |
|
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 |
9.36 |
|
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. |
9.36 |
|
High-throughput sequencing of pluripotent cells |
9.3 |
|
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions |
9.3 |
|
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer |
9.24 |
|
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC |
9.23 |
|
scRNASeq analysis of cycling cardiomyocytes |
9.22 |
|
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons |
9.2 |
|
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage |
9.18 |
|
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells |
9.18 |
|
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer |
9.15 |
|
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression |
9.12 |
|
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes |
9.11 |
|
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression |
9.06 |
|
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells |
9.04 |
|
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control |
9.03 |
|
Expression and functions of long noncoding RNAs during human T helper cell differentiation |
8.98 |
|
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) |
8.97 |
|
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation |
8.97 |
|
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death |
8.96 |
|
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] |
8.94 |
|
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines |
8.94 |
|
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 |
8.88 |
|
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes |
8.83 |
|
RNA-seq analysis of RALD iPSCs after in vitro differentiation |
8.81 |
|
Regulating Interleukin-2 activity with engineered receptor signaling clamps |
8.78 |
|
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M |
8.76 |
|
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells |
8.64 |
|
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] |
8.63 |
|
HNF1 regulates critical functions of the human epididymis epithelium. |
8.63 |
|
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device |
8.63 |
|
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers |
8.62 |
|
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells |
8.59 |
|
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] |
8.54 |
|
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia |
8.54 |
|
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 |
8.53 |
|
STRIPAK directs PP2A activity to promote oncogenic transformation |
8.5 |
|
The human blood-nerve barrier transcriptome |
8.47 |
|
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential |
8.47 |
|
Developmental stage specific chromosome architecture in human erythroid cells |
8.45 |
|
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) |
8.45 |
|
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A |
8.42 |
|
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 |
8.38 |
|
MYC dependent mRNA translation shapes gene expression and cell biology |
8.38 |
|
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells |
8.35 |
|
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] |
8.33 |
|
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells |
8.27 |
|
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD |
8.27 |
|
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma |
8.26 |
|
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns |
8.23 |
|
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells |
8.2 |
|
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses |
8.2 |
|
miR941 overexpression experiment |
8.15 |
|
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function |
8.07 |
|
Mitochondrial dsRNA triggers antiviral signalling in humans |
8.02 |
|
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq |
8.0 |
|
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia |
7.95 |
|
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) |
7.94 |
|
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma |
7.92 |
|
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons |
7.9 |
|
Ebola virus (EBOV) infection of ARPE-19 cells |
7.88 |
|
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin |
7.85 |
|
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma |
7.84 |
|
Lipid degradation promotes prostate cancer cell survival |
7.81 |
|
Paxillin regulates genomic networks in prostate cancer [PC3] |
7.78 |
|
The DPYSL2 gene connects mTOR and schizophrenia |
7.78 |
|
The mechanism of HHT in treating acute myeloid leukemia on RNA level. |
7.74 |
|
SRSF1 role in cellular gene expression and splicing |
7.66 |
|
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering |
7.64 |
|
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C |
7.61 |
|
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer |
7.55 |
|
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends |
7.53 |
|
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia |
7.5 |
|
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor |
7.49 |
|
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes |
7.47 |
|
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) |
7.45 |
|
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells |
7.45 |
|
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. |
7.44 |
|
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] |
7.39 |
|
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition |
7.39 |
|
Statins modulate endothelial transcriptional profile by inhibiting EZH2 |
7.36 |
|
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES |
7.32 |
|
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. |
7.32 |
|
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. |
7.32 |
|
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) |
7.29 |
|
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 |
7.28 |
|
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome |
7.2 |
|
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia |
7.19 |
|
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) |
7.19 |
|
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets |
6.99 |
|
RNA-seq of RKO cells with cTAZ KO or putback |
6.96 |
|
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. |
6.93 |
|
Human HAP1 cells before and after nutrient deprivation |
6.93 |
|
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation |
6.93 |
|
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] |
6.9 |
|
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) |
6.86 |
|
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery |
6.86 |
|
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease |
6.85 |
|
The cohesin complex prevents Myc-induced replication stress |
6.83 |
|
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine |
6.81 |
|
ARID1A and ARID1B loss in HCT116 cells |
6.81 |
|
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression |
6.77 |
|
Total RNA-seq in ALL-SIL upon TLX1 knockdown |
6.77 |
|
Identification of HOXB13 target genes responsive to BET inhibitors |
6.75 |
|
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells |
6.74 |
|
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] |
6.69 |
|
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner |
6.69 |
|
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 |
6.58 |
|
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway |
6.52 |
|
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes |
6.42 |
|
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. |
6.4 |
|
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding |
6.35 |
|
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] |
6.33 |
|
RNA seq with AML (NB4) cells upon FTO inhibition |
6.33 |
|
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] |
6.32 |
|
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify |
6.3 |
|
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells |
6.29 |
|
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics |
6.22 |
|
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) |
6.18 |
|
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) |
6.16 |
|
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis |
6.14 |
|
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] |
6.13 |
|
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues |
6.06 |
|
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 |
6.03 |
|
Transcriptional profiling of microglia; current state of the art and future perspectives |
6.03 |
|
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells |
6.0 |
|
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen |
5.99 |
|
RNA editing in nascent RNA affects pre-mRNA splicing |
5.95 |
|
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation |
5.86 |
|
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture |
5.86 |
|
Systematic discovery of endogenous human ribonucleoprotein complexes |
5.83 |
|
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) |
5.82 |
|
Tracking distinct RNA populations using efficient and reversible covalent chemistry |
5.8 |
|
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets |
5.75 |
|
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF |
5.72 |
|
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression |
5.71 |
|
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] |
5.71 |
|
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. |
5.7 |
|
RNA splicing alteration on glioblastoma and normal neural stem cells |
5.54 |
|
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) |
5.53 |
|
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity |
5.51 |
|
Aneuploidy-induced cellular stresses limit autophagic degradation. |
5.41 |
|
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. |
5.39 |
|
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 |
5.32 |
|
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] |
5.27 |
|
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability |
5.27 |
|
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells |
5.25 |
|
Cell cycle dynamics of human pluripotent stem cells primed for differentiation |
5.24 |
|
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment |
5.24 |
|
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment |
5.24 |
|
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. |
5.21 |
|
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] |
5.21 |
|
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients |
5.17 |
|
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients |
5.17 |
|
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing |
5.15 |
|
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes |
5.11 |
|
Transcriptome of activated human and mouse MAIT cells |
5.04 |
|
RNA-sequencing of the GSI treatment of the CUTLL1 cell line |
5.0 |
|
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts |
4.9 |
|
Functional interdependency of BRD4 and DOT1L in MLL leukaemia |
4.9 |
|
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 |
4.9 |
|
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) |
4.89 |
|
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling |
4.85 |
|
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] |
4.85 |
|
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia |
4.84 |
|
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD |
4.82 |
|
Global response to chemotherapy-induced apoptosis |
4.79 |
|
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) |
4.73 |
|
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] |
4.68 |
|
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential |
4.63 |
|
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx |
4.63 |
|
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx |
4.63 |
|
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression |
4.6 |
|
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma |
4.55 |
|
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment |
4.54 |
|
METTL3 and WTAP |
4.51 |
|
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) |
4.47 |
|
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes |
4.47 |
|
ADAR1-editing of cellular and measles virus-derived duplex RNA |
4.47 |
|
Genome-wide analysis of the Integrator complex |
4.37 |
|
Genome-wide analysis of the Integrator complex (HTS) |
4.37 |
|
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data |
4.36 |
|
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells |
4.34 |
|
IRF1 regulates IFN dependent and independent gene expression |
4.28 |
|
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. |
4.23 |
|
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] |
4.2 |
|
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide |
4.13 |
|
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. |
4.1 |
|
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. |
4.06 |
|
Differentiation enhances Zika virus infection in neuronal brain cells |
4.05 |
|
LIN28A Over-expression RNAseq |
3.99 |
|
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells |
3.92 |
|
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide |
3.78 |
|
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit |
3.78 |
|
mRNA expression in human DAOY cells |
3.77 |
|
Determining mRNA half-lives on a transcriptome-wide scale |
3.7 |
|
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons |
3.68 |
|
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex |
3.66 |
|
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome |
3.66 |
|
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells |
3.65 |
|
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions |
3.6 |
|
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells |
3.56 |
|
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] |
3.55 |
|
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection |
3.55 |
|
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation |
3.55 |
|
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis |
3.54 |
|
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium |
3.52 |
|
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line |
3.44 |
|
Human Tfh cell RNA bulk sequencing |
3.39 |
|
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 |
3.38 |
|
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer |
3.34 |
|
Transcriptome landscape of HeLa response upon triamcinolone acetonide |
3.29 |
|
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors |
3.24 |
|
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block |
3.22 |
|
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition |
3.22 |
|
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) |
3.2 |
|
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition |
3.16 |
|
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer |
3.14 |
|
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells |
3.13 |
|
Gene expression profile in breast cancer cells |
3.13 |
|
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia |
3.12 |
|
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes |
3.11 |
|
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] |
3.11 |
|
hnRNP C is a key regulator of protein synthesis in mitosis |
3.07 |
|
FOXP2's impact on the primate transcriptome |
3.03 |
|
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) |
3.02 |
|
Investigate A2M treatment on human prostate cancer xenograft in mice |
2.99 |
|
Investigate A2M treatment on human prostate cancer and mouse liver |
2.99 |
|
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles |
2.95 |
|
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? |
2.94 |
|
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis |
2.86 |
|
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition |
2.83 |
|
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] |
2.83 |
|
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function |
2.8 |
|
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] |
2.73 |
|
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control |
2.71 |
|
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) |
2.69 |
|
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells |
2.6 |
|
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] |
2.55 |
|
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer |
2.55 |
|
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A |
2.52 |
|
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures |
2.46 |
|
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) |
2.44 |
|
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid |
2.38 |
|
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines |
2.36 |
|
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq |
2.32 |
|
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells |
2.3 |
|
The interplay between SOX4 and SMAD3 in the context of breast cancer |
2.27 |
|
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. |
2.24 |
|
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 |
2.23 |
|
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors |
2.23 |
|
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) |
2.2 |
|
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin |
2.18 |
|
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] |
2.15 |
|
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition |
1.99 |
|
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] |
1.93 |
|
Solid phase chemistry to covalently and reversibly capture thiolated RNA |
1.93 |
|
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions |
1.88 |
|
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells |
1.83 |
|
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits |
1.8 |
|
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells |
1.8 |
|
Deep RNA sequencing of the human placental transcriptome |
1.79 |
|
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] |
1.77 |
|
Specific molecular signatures underlie response to decitabine in CMML |
1.77 |
|
6mer seed toxicity in viral microRNAs |
1.74 |
|
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy |
1.7 |
|
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) |
1.69 |
|
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas |
1.65 |
|
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism |
1.63 |
|
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy |
1.61 |
|
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells |
1.61 |
|
hnRNP L protects mRNAs from nonsense-mediated mRNA decay |
1.58 |
|
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity |
1.52 |
|
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells |
1.48 |
|
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] |
1.46 |
|
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 |
1.46 |
|
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells |
1.45 |
|
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells |
1.3 |
|
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells |
1.28 |
|
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing |
1.27 |
|
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq |
1.27 |
|
Primary Human B-cell Temporal Response to CD40L Stimulation |
1.16 |
|
Gene expressions of H9s in different culture systems |
1.15 |
|
Effect of ILF3 depletion in HeLa cells on RNA steady state levels |
1.09 |
|
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells |
1.08 |
|
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 |
1.07 |
|
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 |
1.04 |
|
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) |
1.03 |
|
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling |
1.03 |
|
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals |
0.91 |
|
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] |
0.9 |
|
Gene expression profile of CRC-derived HILEC |
0.89 |
|
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG |
0.83 |
|
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] |
0.83 |
|
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes |
0.83 |
|
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies |
0.75 |
|
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription |
0.74 |
|
A single-cell transcriptome atlas of the human pancreas |
0.7 |
|
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] |
0.49 |
|
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL |
0.49 |
|
Targeting MTHFD2 in Acute Myeloid Leukemia |
0.45 |
|
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes |
0.42 |
|
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) |
0.41 |
|
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates |
0.41 |
|
siRNA-mediated knockdown |
0.4 |
|
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor |
0.35 |
|
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation |
0.27 |
|
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] |
0.26 |
|
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles |
0.26 |
|
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles |
0.23 |
|
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML |
0.22 |
|
ZIKV infection of monocytes activates inflammasome pathways |
0.2 |
|
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival |
0.2 |
|
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution |
0.16 |
|
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol |
0.12 |
|
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] |
0.12 |
|
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown |
0.09 |
|
Global transcriptome analysis of WT versus HEB-/- hESCs |
0.07 |
|
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection |
0.04 |
|
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) |
0.04 |
|
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming |
0.03 |
|
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles |
0.01 |